The Importance of Regulating E-Cigarettes in Ireland

Jul.31.2022
The Importance of Regulating E-Cigarettes in Ireland
The Irish tobacco policy group chair supports restricting e-cigarettes to promote public health and reduce teen smoking.

Professor Des Cox, the chairman of the Irish Tobacco Policy Group, has commented on the recent opinion piece in the Wall Street Journal titled "Why We Shouldn't Wage War on E-cigarettes", stating that he believes such a battle should indeed be fought.


In 2013, the government launched a bold plan to reduce Ireland's smoking rate to 5% by 2025, ushering in a smoke-free society. As of 2021, however, 18% of Irish adults are still smokers, rendering this ambitious goal unattainable.


Last week's opinion piece argued that Ireland needs to embrace e-cigarettes to help more people quit smoking, but is there evidence to support this approach?


The Oireachtas Health Committee has released a report on the Public Health (Tobacco and Nicotine Inhaling Products) Bill. In addition to recommending a ban on the sale of electronic cigarettes to those under 18, the committee also suggested prohibiting the sale of all flavors except tobacco, introducing plain packaging, and banning all forms of e-cigarette advertising.


Teenagers


The first issue to be addressed is the relationship between electronic cigarettes and youth. According to the findings report from the European School Survey Project on Alcohol and Other Drugs (ESPAD) released by the TobaccoFree Research Institute in 2020, the use of electronic cigarettes by 16-17 year-olds has increased by 50% since 2015.


According to a recent survey by ASH UK, 39% of teenagers have tried e-cigarettes and 18% are current users. The study also found that the number of children aged 11 to 17 who use e-cigarettes has increased from 11.2% in 2021 to 15.7% in 2022.


Of concern is the simultaneous increase in the use of electronic cigarettes and the consumption of disposable e-cigarette products by young people. According to a report, the use of disposable e-cigarettes by this age group has increased seven-fold from 2020 to 2022. Nearly half of the surveyed teenagers reported seeing e-cigarette promotion and specifically on TikTok. There is an urgent need to strengthen regulations around the marketing of e-cigarettes, especially online marketing.


Last week's article raised concerns that banning flavored e-cigarettes would result in an increase in Ireland's smoking population. However, there is no publicly available evidence to support this claim. On the other hand, there is substantial evidence indicating that flavored products attract young people to purchase them, leading them to believe that e-cigarettes are a harmless product.


Although adults may also be attracted to flavored electronic cigarettes, the risks of teenagers and young people starting to use them may outweigh the benefits of former smokers using flavored electronic cigarettes.


Last week's article claimed that vaping is a gateway to smoking. A comprehensive study on the topic has found that teenagers who have used e-cigarettes are three to five times more likely to start smoking compared to those who have never used e-cigarettes.


There is now irrefutable evidence that we must protect children from the lure of smoking and e-cigarettes. Simply banning the sale of e-cigarettes to children under the age of 18 through the proposed public health bill will not be the ultimate solution; government officials need to consider the recommendations of the Oireachtas committee on the bill.


Based on the available evidence, we suggest that electronic cigarettes should be subject to the same packaging, advertising, and marketing restrictions as traditional tobacco products. Ireland should only allow tobacco-flavored e-cigarettes, which would enable former smokers to continue experiencing the taste of tobacco while limiting their use among adolescents and young adults.


Last year, a systematic review was published which analyzed ten randomized controlled trials to investigate whether electronic cigarettes were an effective tool for smoking cessation. The review found no evidence to suggest that electronic cigarettes were more effective than nicotine replacement therapy (NRT), which is approved and regulated for smoking cessation.


The evidence for electronic cigarettes as a tool for quitting smoking is at best mixed, and healthcare professionals should recommend reliable methods such as NRT that have been proven effective through practice, rather than electronic cigarettes. In January, Ireland released its first national smoking cessation guidelines, which did not recommend electronic cigarettes as a tool for quitting smoking due to insufficient evidence and the uncertainty surrounding these products.


Best advice.


In addition, healthcare professionals need to have confidence that the treatments they recommend to patients are safe in order to suggest effective methods of care. In 2020, the Health Research Council conducted a review of over 361 studies on the risks and benefits of e-cigarettes and found that they have negative effects on the heart and lungs.


Some supporters of using e-cigarettes as a tool to quit smoking claim that they are 95% safer than tobacco products. However, this statement lacks scientific evidence and is based on the opinions of a small group of doctors from 2013, when we knew little about the harmful effects of e-cigarettes. While it is important to acknowledge that e-cigarettes pose less harm than tobacco products, they are not without risk and the public needs to be aware of this fact.


The argument that e-cigarettes reduce harm has been overemphasized, as they are not more effective than validated treatment methods, and there is too much uncertainty regarding their long-term safety. Additionally, research indicates that many e-cigarette users continue smoking. The 2018 Healthy Ireland survey revealed that 4 out of every 10 adults who use e-cigarettes also use traditional cigarettes.


In order for electronic cigarettes to become a viable option in harm reduction strategies, they must prove themselves as safe products regulated by the Health Products Regulatory Authority (HPRA) to aid people in quitting smoking.


In summary, the evidence in 2022 does not support the argument that electronic cigarettes are an effective tool for quitting smoking. Their long-term safety is still a cause for serious concern and it has been proven that they are a gateway to smoking for teenagers.


Until more conclusive research becomes available, healthcare professionals should promote safe and effective smoking cessation methods, such as nicotine replacement therapy (NRT), rather than unproven methods like electronic cigarettes. The good news is that most smokers want to quit, and there is help available. The HSE's www.quit.ie service is staffed by experienced and trained professionals who offer validated smoking cessation assistance.


Note: Professor Des Cox serves as the Chair of the Tobacco Policy Group at the Royal College of Physicians of Ireland and as a Respiratory Medicine Consultant at Crumlin Children's Hospital in Ireland.


I am sorry, as an AI language model, I only perform tasks based on a specific prompt or request. Please provide me with the text that needs to be translated to standard journalistic English.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
From Product Innovation to Integrated Solutions: NEXTECH Expands Its Global Heated Tobacco Solutions
From Product Innovation to Integrated Solutions: NEXTECH Expands Its Global Heated Tobacco Solutions
NEXTECH launched its NEXE Pro circumferential-heating tobacco stick globally at InterTabac 2026, as the company expands from product innovation into broader heated tobacco solutions. Amid intensifying competition across global HTP markets, NEXTECH is strengthening its R&D, manufacturing and pre-launch support capabilities to serve different types of business customers.
Industry Insight
Sep.15
Malaysia's Poisons Board Backs New Vape Nicotine Exemption After Unanimously Opposing 2023 Proposal
Malaysia's Poisons Board Backs New Vape Nicotine Exemption After Unanimously Opposing 2023 Proposal
Malaysia's Poisons Board has endorsed Health Minister Dzulkefly Ahmad's proposal to exempt liquid nicotine used in vaping products from the Poisons List, according to a November 2, 2026, report by CodeBlue. The Board unanimously opposed a similar proposal in 2023, but the government proceeded with the exemption. The Kuala Lumpur High Court invalidated the 2023 decision in May 2026, and the government withdrew its appeal in August. No new ministerial order has been published. The development raises questions about the interaction between Malaysia's two regulatory frameworks and the treatment of RM354.51 million in excise duties collected on e-cigarette and vape products between May 2023 and June 11, 2026.
Regulations
Nov.03
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10
Italian Financial Police Seize 4.3 Million E-Cigarettes and Smoking Accessories; 28 Reported to Judicial Authorities Across Operations
Italian Financial Police Seize 4.3 Million E-Cigarettes and Smoking Accessories; 28 Reported to Judicial Authorities Across Operations
Italy's Guardia di Finanza announced on October 28 that officers in Latina province had seized approximately 4.3 million e-cigarettes and smoking accessories at an unauthorized warehouse in an operation involving restrictions on the possession and sale of tobacco-related products. Another 300,000 suspected counterfeit or unsafe items were confiscated during separate inspections, bringing total seizures across the operations to more than 4.6 million products. Twenty-eight people were reported to judicial authorities over suspected smuggling and counterfeiting offenses. Officials did not disclose separate vape quantities, the value of the merchandise or alleged violations associated with individual brands.
Enforcement
Oct.29
2Firsts On-Site | CTIHK Showcases Nicotine Pouches, Heated Tobacco and Chinese Cigars at InterTabac 2026
2Firsts On-Site | CTIHK Showcases Nicotine Pouches, Heated Tobacco and Chinese Cigars at InterTabac 2026
At InterTabac 2026 in Dortmund, China Tobacco International (HK) Company Limited (CTIHK) is exhibiting across two separate booths in Hall 5 and Hall 4. Products observed by 2Firsts include heated tobacco products, nicotine pouches, Chinese cigars and tobacco leaf. Nicotine pouch products on display include TOOP, Shuangxi and Ashima.
Market
Sep.16